The invention provides antibodies that specifically bind to Kallidin or des-Arg10-Kallidin. The invention also provides pharmaceutical compositions, as well as nucleic acids encoding anti-Kallidin or des-Arg10-Kallidin antibodies, recombinant expression vectors and host cells for making such antibodies, or fragments thereof. Methods of using antibodies of the invention to modulate Kallidin or des-Arg10-Kallidin activity or detect Kallidin or des-Arg10-Kallidin or, either in vitro or in vivo, are also provided by the invention. The invention further provides methods of making antibodies that specifically bind to des-Arg9- Bradykinin and des-Arg10-Kallidin-like peptide.本發明提供特異性結合至胰激肽或去-Arg10-胰激肽之抗體。本發明亦提供藥物組合物,以及編碼抗胰激肽或抗去-Arg10-胰激肽抗體之核酸、重組表現載體及用於製備此等抗體或其片段之宿主細胞。本發明亦提供在活體外或活體內使用本發明抗體調節胰激肽或去-Arg10-胰激肽活性或檢測胰激肽或去-Arg10-胰激肽之方法。本發明進一步提供製備特異性結合至去-Arg9-緩激肽及去-Arg10-胰激肽樣肽之抗體的方法。